IGLL5.md
... ...
@@ -2,18 +2,15 @@
2 2
bibliography: 'morinlab.bib'
3 3
csl: 'NLM.csl'
4 4
link-citations: true
5
+nocite: |
6
+ @deschGenotypingCirculatingTumor2020, @paneaWholeGenomeLandscape2019, @russler-germainMutationsAssociatedProgression2023
5 7
---
6 8
[[_TOC_]]
7 9
8 10
9 11
## Relevance tier by entity
10 12
11
-|Entity|Tier|Description |
12
-|:------:|:----:|-----------------------------------------|
13
-|![PMBL](images/icons/PMBL_tier2.png)|2|relevance in PMBL/cHL/GZL not firmly established[@deschGenotypingCirculatingTumor2020]|
14
-|![BL](images/icons/BL_tier2.png) |2 | aSHM target; Although recurrent, the relevance of mutations in BL is tenuous [@paneaWholeGenomeLandscape2019]|
15
-|![DLBCL](images/icons/DLBCL_tier2.png) |2 | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |
16
-|![FL](images/icons/FL_tier2.png) |2 | aSHM target; Although recurrent, the relevance of mutations in FL is tenuous [@russler-germainMutationsAssociatedProgression2023]|
13
+[[include:table1_IGLL5]]
17 14
18 15
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
19 16